FindTrial
Sign In

Study on gene screening of patients with venous thromboembolism in Guangxi

Study on gene screening of patients with venous thromboembolism in Guangxi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059036
Enrollment
Unknown
Registered
2022-04-23
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Interventions

Healthy persons, patients with unprovoked vein thrombosis
A patient with provoked vein thrombosis:none

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with initial VTE were older than 18 years and did not receive warfarin anticoagulant therapy.

Exclusion criteria

Exclusion criteria: 1. Patients with antiphospholipid syndrome, tumor, active or previous malignant tumor (excluding skin cancer), infection within the first two weeks of enrollment, or current pregnancy.

Design outcomes

Primary

MeasureTime frame
Transcriptome gene;—

Countries

China

Contacts

Public ContactXiao Qin

The First Affiliated Hospital of Guangxi Medical University

15200561225@163.com+86 13977100990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026